- Home
- PCYO vs TRDA Comparison
PCYO vs TRDA Comparison
Compare PCYO & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- TRDA
- Stock Information
- Founded
- PCYO 1976
- TRDA 2016
- Country
- PCYO United States
- TRDA United States
- Employees
- PCYO N/A
- TRDA N/A
- Industry
- PCYO Water Supply
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- PCYO Utilities
- TRDA Health Care
- Exchange
- PCYO Nasdaq
- TRDA Nasdaq
- Market Cap
- PCYO 267.7M
- TRDA 233.5M
- IPO Year
- PCYO N/A
- TRDA 2021
- Fundamental
- Price
- PCYO $11.56
- TRDA $5.46
- Analyst Decision
- PCYO
- TRDA Strong Buy
- Analyst Count
- PCYO 0
- TRDA 3
- Target Price
- PCYO N/A
- TRDA $25.67
- AVG Volume (30 Days)
- PCYO 36.4K
- TRDA 215.2K
- Earning Date
- PCYO 11-12-2025
- TRDA 11-04-2025
- Dividend Yield
- PCYO N/A
- TRDA N/A
- EPS Growth
- PCYO 123.89
- TRDA N/A
- EPS
- PCYO 0.56
- TRDA N/A
- Revenue
- PCYO $27,447,000.00
- TRDA $79,476,000.00
- Revenue This Year
- PCYO N/A
- TRDA N/A
- Revenue Next Year
- PCYO N/A
- TRDA N/A
- P/E Ratio
- PCYO $19.99
- TRDA N/A
- Revenue Growth
- PCYO 40.36
- TRDA N/A
- 52 Week Low
- PCYO $9.65
- TRDA $4.93
- 52 Week High
- PCYO $14.63
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- PCYO 70.43
- TRDA 50.40
- Support Level
- PCYO $10.80
- TRDA $5.08
- Resistance Level
- PCYO $11.64
- TRDA $5.51
- Average True Range (ATR)
- PCYO 0.33
- TRDA 0.28
- MACD
- PCYO 0.09
- TRDA 0.03
- Stochastic Oscillator
- PCYO 95.73
- TRDA 67.16
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.